Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingApr 22, 2026SLMD Benzoyl Peroxide Acne LotionChemical contamination: Presence of benzeneOwen Biosciences Inc. · D-0455-2026Class IIOngoingApr 22, 2026SLMD BP Acne Spot TreatmentChemical contamination: Presence of benzeneOwen Biosciences Inc. · D-0454-2026Class IIOngoingApr 22, 2026HydroPeptide CLEAR ALLIANCE SERUMChemical contamination: Presence of benzeneOwen Biosciences Inc. · D-0453-2026Class IIOngoingApr 22, 2026FHF Farmhouse FreshChemical contamination: Presence of benzeneOwen Biosciences Inc. · D-0452-2026Class IIOngoingApr 22, 2026Cinacalcet Hydrochloride TabletsCGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limitCipla USA, Inc. · D-0451-2026Class IIOngoingApr 22, 2026Cinacalcet Hydrochloride TabletsCGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limitCipla USA, Inc. · D-0450-2026Class IIOngoingApr 22, 2026Cinacalcet Hydrochloride TabletsCGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limitCipla USA, Inc. · D-0449-2026Class IIOngoingApr 15, 2026Clonidine Transdermal SystemCGMP Deviations: use of an unapproved raw materialTeva Pharmaceuticals USA, Inc · D-0474-2026Class IIOngoingApr 15, 2026Clonidine Transdermal SystemCGMP Deviations: use of an unapproved raw materialTeva Pharmaceuticals USA, Inc · D-0473-2026Class IIOngoingApr 15, 2026Clonidine Transdermal SystemCGMP Deviations: use of an unapproved raw materialTeva Pharmaceuticals USA, Inc · D-0472-2026Class IIOngoingApr 15, 2026GE Healthcare OmnipaquePresence of particulate matterGE Healthcare Ireland Limited · D-0448-2026Class IIOngoingApr 15, 2026GE Healthcare OmnipaquePresence of particulate matterGE Healthcare Ireland Limited · D-0447-2026Class IIOngoingApr 15, 2026Isotretinoin CapsulesSuperpotent and SubpotentTeva Pharmaceuticals USA, Inc · D-0446-2026Class IIOngoingApr 15, 2026Isotretinoin CapsulesSuperpotent and SubpotentTeva Pharmaceuticals USA, Inc · D-0445-2026Class IIOngoingApr 15, 2026Xanax XRFailed Dissolution SpecificationsViatris, Inc. · D-0444-2026Class IIOngoingApr 15, 2026Artificial Tears Lubricant Eye DropsLack of Assurance of SterilityPreferred Pharmaceuticals, Inc. · D-0443-2026Class IIOngoingApr 15, 2026Vancomycin HCLLack of Assurance of Sterility; blue Break-Off-Part could detach from the administration portFagron Compounding Services · D-0442-2026Class IIOngoingApr 15, 2026Vancomycin HCILack of Assurance of Sterility; blue Break-Off-Part could detach from the administration portFagron Compounding Services · D-0441-2026Class IIOngoingApr 15, 2026Vancomycin HCILack of Assurance of Sterility; blue Break-Off-Part could detach from the administration portFagron Compounding Services · D-0440-2026Class IIOngoingApr 15, 2026norepinephrine BitartrateLack of Assurance of Sterility; blue Break-Off-Part could detach from the administration portFagron Compounding Services · D-0439-2026Class IIOngoingApr 15, 2026norepinephrine BitartrateLack of Assurance of Sterility; blue Break-Off-Part could detach from the administration portFagron Compounding Services · D-0438-2026Class IIOngoingApr 15, 20265% Dextrose InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0437-2026Class IIOngoingApr 15, 20265% Dextrose InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0436-2026Class IIOngoingApr 15, 20265% Dextrose InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0435-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0434-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0433-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0432-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0431-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0430-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0429-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0428-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0427-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0426-2026Class IIOngoingApr 15, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0425-2026Class IIOngoingApr 15, 20260.45% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Kabi USA, LLC · D-0424-2026Class IIOngoingApr 15, 2026Lanreotide InjectionLack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.Cipla USA, Inc. · D-0423-2026Class IIOngoingApr 15, 2026Lanreotide InjectionLack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.Cipla USA, Inc. · D-0422-2026Class IOngoingApr 8, 2026Magnesium Sulfate in Water for InjectionProduct mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.Amneal Pharmaceuticals, LLC · D-0478-2026Class IIOngoingApr 8, 2026Prazosin Hydrochloride CapsulescGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.Appco Pharma LLC · D-0421-2026Class IIOngoingApr 8, 2026Prazosin Hydrochloride CapsulescGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.Appco Pharma LLC · D-0420-2026

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.